Complete Remissions in Metastatic Breast Cancer Treated with Combination Drug Therapy
Sewa S. Legha(The University of Texas MD Anderson Cancer Center), E. J. Freireich, Aman U. Buzdar(Nottingham City Hospital), George R. Blumenschein(The University of Texas MD Anderson Cancer Center), Edmund A. Gehan(Georgetown University), Terry L. Smith(The University of Texas MD Anderson Cancer Center), Kenneth D. Swenerton, G. P. Bodey(The University of Texas MD Anderson Cancer Center), Gabriel N. Hortobágyi(The University of Texas MD Anderson Cancer Center)
Cited by 92
Related Papers
PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients
|Cancer Cell|2004|1.9k
Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas
|Journal of neurosurgery|1978|1.7k
Local Consolidative Therapy Vs. Maintenance Therapy or Observation for Patients With Oligometastatic Non–Small-Cell Lung Cancer: Long-Term Results of a Multi-Institutional, Phase II, Randomized Study
|Journal of Clinical Oncology|2019|1.3k